Rebuilding the Body's First Line of Defense

We're a biotech company developing durable, curative therapies for chronic diseases—from IBD to COPD. Where medicine stops at symptom control, we start. Powered by CRISPR-optimized stem cells and AI-driven biomaterials.

Join researchers, clinicians, and 2165+ others on the waitlist.